NAGASE & (8012) FY2026 Q3 Earnings Report

Quick View

Executive Summary

Operating income increased 7.1% and net income increased 15.0%, compared with revenue growth of 0.8%, resulting in earnings growth exceeding the increase in revenue. Revenue was ¥724.07B (+0.8% YoY), operating income was ¥33.21B (+7.1%), ordinary income was ¥33.60B (+9.4%), and net income was ¥25.52B (¥22.29B in the previous year). The primary drivers of earnings growth were substantial increases in the Electronics & Energy segment and rapid profit expansion in Life & Healthcare, which offset declines in Functional Materials and Mobility.

Factors Affecting Performance

【Revenue】Revenue was ¥724.07B, essentially flat at +0.8% YoY. Sales of modified epoxy resins for semiconductors used in AI servers by Nagase ChemteX and food ingredients sold by the Prinova Group increased, while sales related to automobiles in the Functional Materials and Mobility businesses declined, resulting in only a slight increase in overall revenue.

【Profit and Loss】Operating income increased to ¥33.21B (+7.1% YoY), while ordinary income rose to ¥33.60B (+9.4%), exceeding the rate of revenue growth. The gross profit margin improved to 19.2% from the previous year, with the increased contribution of Electronics & Energy supporting profitability improvement. In extraordinary income and losses, gains on sales of investment securities of ¥2.77B and gains on negative goodwill of ¥1.78B boosted extraordinary income, while losses associated with the withdrawal from the China business and other items were recorded as extraordinary losses, resulting in a net positive contribution of ¥1.75B. Net income of ¥25.52B reflects tax expenses and other items relative to ordinary income of ¥33.60B, and the difference from ordinary income includes the boost from extraordinary income and losses. In conclusion, the Company achieved both revenue and earnings growth.

Segment Analysis

The largest share of revenue was generated by LifeAndHealthcare (Life & Healthcare, revenue of ¥228.77B, or 31.6% of the total), positioning it as the “core business.” In terms of operating income, ElectronicsAndEnergy (Electronics & Energy, operating income of ¥11.34B) made the largest profit contribution among all segments, with a profit margin of 8.7%; its operating income increased +28.0% YoY and drove overall earnings growth. Operating income in Life & Healthcare was ¥6.98B, a substantial +124.1% YoY increase, supported by higher food ingredient sales by the Prinova Group and improved profitability at Nagase Viita. Meanwhile, Mobility (¥2.74B, profit margin of 2.8%) recorded lower earnings due to declining automobile-related demand, while FunctionalMaterials (¥6.76B, profit margin of 5.8%) also reported lower earnings due to reduced demand for paint materials. There was a substantial gap in profit margins among the segments, with Mobility at only 2.8% compared with 8.7% for Electronics & Energy.

Key Financial Indicators

Profitability: Operating margin was 4.6% and ROE was 6.1% (combined with an equity ratio of 48.4%, indicating a low level of leverage).
Cash flow quality: Operating Cash Flow (OCF) of ¥29.34B was approximately 1.15 times net income of ¥25.52B, providing sufficient cash support for earnings. Free Cash Flow was negative ¥13.86B.
Investment efficiency: Capital expenditures of ¥21.81B were approximately 1.80 times depreciation and amortization of ¥12.10B, indicating that the Company is in a phase of growth investment.
Financial soundness: The equity ratio was 48.4% and the current ratio was 183.4%, both healthy levels.

Cash Flow Analysis

Operating Cash Flow was ¥29.34B, or 1.15 times net income, and improved by +37.0% YoY; however, an increase of ¥12.30B in trade receivables and an increase of ¥1.99B in inventories absorbed cash. Investing Cash Flow was negative ¥43.20B, primarily due to capital expenditures of ¥21.81B and M&A investments, including the acquisition of shares in subsidiaries. Financing Cash Flow was negative ¥10.79B, with share repurchases of ¥18.43B being the primary source of cash outflow. FCF (Operating Cash Flow + Investing Cash Flow) was negative ¥13.86B, indicating that investment and shareholder returns during the period could not be funded solely by operating cash flow. Cash generation requires monitoring, and the trend of increasing working capital will determine future cash-generation capacity.

Earnings Quality

Net income was ¥25.52B against ordinary income of ¥33.60B, with the difference primarily attributable to income taxes and other taxes of ¥9.83B and profit attributable to non-controlling interests of ¥0.54B. Extraordinary income of ¥5.25B (including gains on sales of investment securities of ¥2.77B and gains on negative goodwill of ¥1.78B) and extraordinary losses of ¥3.51B (including losses related to the withdrawal from the China business) resulted in a net positive contribution of ¥1.75B, meaning that temporary factors contributed to a certain extent to net income growth. Non-operating income of ¥3.85B was approximately 0.5% of revenue, limiting its impact on the recurring earnings structure. Operating Cash Flow exceeded net income, and there are no major concerns from an accrual perspective.

Earnings Forecast and Guidance

Progress against the full-year forecast (revenue of ¥964.00B, operating income of ¥40.70B, and ordinary income of ¥40.60B) was 75.1% for revenue, 81.6% for operating income, and 82.8% for ordinary income. Profit progress exceeded the standard 75% pace by 6–8pt. The Company maintained its full-year outlook, viewing the progress as within the expected range, with demand for semiconductors at Nagase ChemteX and strong performance by the Prinova Group offsetting each other. Required operating income in Q4 is approximately ¥7.5B, and the required profit margin is below the cumulative actual result of 4.6%, indicating a certain degree of conservatism in the full-year forecast.

Shareholder Returns

The Q2 dividend was ¥45.00 per share, and the full-year forecast dividend is ¥100.00. The payout ratio is approximately 33.3% based on forecast full-year EPS of ¥300.53. The Company conducted share repurchases of ¥18.43B (in addition to ¥20B cumulatively completed, with an additional ¥3B authorized), resulting in a high total return ratio when dividends and share repurchases are combined relative to net income of ¥25.52B. In the final year of its medium-term management plan, the Company has stated a policy of maintaining a total return ratio of 100% for a limited period of 2 years, while using debt to fund growth investments.

Catalysts

【Short Term】The achievement status of the full-year earnings forecast in Q4, demand for semiconductors used in AI servers at Nagase ChemteX, and developments in U.S.–China relations.

【Long Term】Progress in the growth strategy through potential investments totaling approximately ¥80B in 3 priority areas, including the expansion of the SACHEM Asian business (targeting gross profit of approximately ¥4B in FY2030), expansion of the food business through the acquisition of Aplinova (targeting approximately ¥2B in the same period), and the development of the diagnostics business through the establishment of Nagase Diagnostics (targeting approximately ¥4B around 2030).

Industry Benchmark (Reference; Compiled by the Company)

Industry Benchmark (trading)

Profitability and Returns

Both the operating margin and net profit margin exceeded the industry median, placing profitability relatively high within the industry.

Growth and Capital Efficiency

The revenue growth rate was substantially below the industry median, indicating that top-line growth was relatively weak within the industry.

※Source: Compiled by the Company

Risk Factors

1. Profitability Structure Risk: The gross profit margin of 19.2% is below 20%, creating a structure in which raw material prices and foreign exchange fluctuations can readily affect margins. If demand declines in automobile-related businesses (Mobility and Functional Materials) continue, the gap in profit margins among segments could widen further.

2. Working Capital and Cash Conversion Risk: Increases of ¥12.30B in trade receivables and ¥1.99B in inventories pressured Operating Cash Flow, resulting in negative Free Cash Flow of ¥13.86B. As capital expenditures and M&A investments continue, improvement in working capital will be key to future cash-generation capacity.

3. Extraordinary Income and Loss Dependence Risk: Some portion of the 15.0% increase in net income depended on extraordinary income, including gains on sales of investment securities of ¥2.77B and gains on negative goodwill of ¥1.78B. The net positive contribution of ¥1.75B, after extraordinary losses including losses related to the withdrawal from the China business, has low repeatability from the next fiscal year onward.

Key Takeaways from the Earnings Results

1. Operating income in the Electronics & Energy segment increased substantially by +28.0% YoY, driving Company-wide earnings growth. Whether the capture of demand for materials used in semiconductors for AI servers will lead to structural margin improvement will be a key area of focus going forward.

2. Operating income in the Life & Healthcare segment expanded rapidly by +124.1% YoY, increasing its contribution to Company-wide performance as the core business with the largest revenue composition. The focus will be on the progress of efficiency improvements at the Prinova Group and the sustainability of demand for food ingredients.

3. The total return ratio, including share repurchases of ¥18.43B, is at a level exceeding net income. The sustainability of capital allocation while Free Cash Flow is negative will be a key focus, particularly in balancing it with financial soundness (equity ratio of 48.4%).

Theoretical Share Price (Reference Value)

Sensitivity: ¥3,786–¥4,009 at ±1% for the cost of equity, and ¥3,892–¥3,897 at ±0.1 for ω.

Notes:

• Goodwill amortization of ¥28.1 per share is added back to earnings (to reflect a non-cash expense and comparability with IFRS companies).
• Because forecast ROE is below the cost of equity, the theoretical value is below book value per share.
• Net assets as of the quarter-end are used (there is a timing gap relative to the full-year forecast).

(Calculation model: Residual Income Model (Ohlson-type, explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices)

---

This report is an earnings analysis document automatically generated by AI through integrated analysis of XBRL earnings summary data and PDF earnings presentation materials. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own responsibility, after consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 results were solid, with profit growth materially outpacing essentially flat revenue, although working-capital intensity and cash conversion remain the principal operational constraints. Revenue rose 0.8% YoY to ¥724.1bn. Operating income increased 7.1% to ¥33.2bn. Ordinary income rose 9.4% to ¥33.6bn. Profit attributable to owners of parent increased 15.0% to ¥25.0bn. Gross profit rose to ¥138.9bn and the gross margin expanded by approximately 91bp YoY to 19.2%. SG&A expenses rose 5.5% to ¥105.7bn, substantially faster than revenue growth, but gross-profit expansion was sufficient to lift the operating margin by approximately 27bp to 4.6%. The attributable net margin improved by approximately 43bp to 3.5%. The annualized ROE was 8.0%, supported by a 3.5% net margin, annualized asset turnover of 1.122x, and 2.07x financial leverage. Profit before tax exceeded ordinary income by ¥1.7bn, reflecting a net extraordinary gain, including ¥2.8bn of gains on sales of investment securities and a ¥1.8bn gain on negative goodwill, partly offset by ¥2.6bn of business-exit costs. Consequently, the 15% increase in net income includes non-recurring support and should not be interpreted entirely as an improvement in recurring operating earnings. Operating cash flow of ¥29.3bn exceeded attributable net income, producing an OCF/net-income ratio of 1.17x and a low accruals ratio of -0.5%, both constructive indicators of accounting earnings quality. However, OCF/EBITDA cash conversion was only 0.65x, while receivable days were 126 days, inventory days 71 days, and the cash conversion cycle 128 days. Investment cash outflow of ¥43.2bn, including ¥19.1bn for subsidiary acquisitions and ¥21.8bn of capital expenditure, resulted in reported free cash flow of negative ¥13.9bn. The Q3 revenue progress rate is 75.1% of the full-year forecast, in line with the 75% seasonal benchmark, while operating-income progress is stronger at 81.6%. The full-year operating-income forecast of ¥40.7bn implies only about ¥7.5bn of Q4 operating income, leaving the company positioned to meet its plan if trading conditions and margins remain stable. Near-term priorities are sustaining gross-margin gains, converting the enlarged receivable and inventory base into cash, and demonstrating returns from elevated investment and acquisition activity.

Profitability Analysis

The annualized DuPont framework produces ROE of 8.0%, comprising a 3.5% net profit margin, annualized asset turnover of 1.122x, and financial leverage of 2.07x. The margin component improved most visibly at the operating level: gross margin expanded to 19.2% from approximately 18.3% a year earlier, and operating margin rose to 4.6% from approximately 4.3%. This indicates that improved gross-profit capture more than offset SG&A growth of 5.5%, which exceeded revenue growth of 0.8%. The resulting operating leverage was favorable, as operating income grew 7.1% on modest top-line growth. Nevertheless, the 4.6% EBIT margin remains below the 5% efficiency alert threshold and indicates limited tolerance for renewed gross-margin pressure or further cost escalation. Net-margin improvement to 3.5% was stronger than the operating-margin movement because non-operating expenses declined and the period included a net ¥1.7bn extraordinary gain. The five-factor profile is otherwise sound: the tax burden was 0.707, the effective tax rate was 27.8%, and the interest burden was 1.065, with interest income and other below-EBIT items exceeding interest expense on the reported formulation. Interest coverage was robust at 13.34x on EBIT and 18.20x on EBITDA. As a JGAAP reporter, Nagase amortized ¥2.2bn of goodwill; EBITDA before goodwill amortization was ¥47.5bn, versus reported EBITDA of ¥45.3bn. Goodwill amortization represented approximately 4.8% of EBITDA, a modest rather than material distortion to comparability with IFRS peers. The margin uplift appears operationally encouraging, but its sustainability depends on maintaining gross-profit improvement while containing SG&A growth and avoiding reliance on securities-sale gains.

Growth Assessment

Revenue growth of 0.8% indicates a subdued top-line environment, whereas the 7.1% increase in operating income demonstrates improved monetization of sales. Gross profit grew approximately 5.9% YoY to ¥138.9bn, faster than SG&A growth of approximately 5.5%, creating positive operating leverage. Full-year guidance calls for revenue of ¥964.0bn, up 2.0% YoY, and operating income of ¥40.7bn, up 4.1%. Q3 revenue represents 75.1% of guidance, only 0.1 percentage points above the standard 75% progress rate. Operating-income progress is 81.6%, 6.6 percentage points ahead of the standard pace, while ordinary-income progress is 82.8%, 7.8 percentage points ahead. Attributable-income progress is 79.3% of the ¥31.5bn forecast, 4.3 percentage points ahead of the standard pace. These progress rates provide a reasonable cushion, although they also imply slower sequential profit generation in Q4 than the cumulative Q3 run rate. The period included ¥19.1bn of acquisition spending and eight newly consolidated subsidiaries, which can support future scale and capabilities but raises the execution requirement for post-acquisition integration. Capital expenditure of ¥21.8bn was 1.80x depreciation and amortization, evidencing an expansionary investment posture. PPE increased 28.3% YoY to ¥117.6bn, reinforcing that the company is deploying capital for future operations. The key test for growth quality is whether these investments generate incremental gross profit and cash flow without further lengthening the cash conversion cycle.

Financial Health

Liquidity is sound, with a current ratio of 183.4%, a quick ratio of 134.3%, and working capital of ¥257.2bn. Current assets of ¥565.4bn comfortably exceed current liabilities of ¥308.3bn. Cash and deposits of ¥43.5bn cover short-term loans of ¥22.5bn by 1.93x, mitigating immediate refinancing risk. The reported debt-to-equity ratio of 1.07x is moderately geared but remains well below the 2.0x level associated with aggressive leverage. Debt/EBITDA of 1.61x and debt/capital of 14.9% also indicate ample debt-service capacity. Long-term loans totaled ¥50.4bn, while bonds payable and commercial paper were ¥40.0bn and ¥54.0bn, respectively, making continued access to short-term funding markets relevant to treasury management. The reported short-term debt ratio was 30.9%, but the strong current and quick ratios limit maturity-mismatch risk. Short-term loans declined 46.8% YoY, or ¥19.8bn, to ¥22.5bn, reflecting reduced reliance on this funding source. Cash and deposits declined 34.4% YoY, or ¥22.8bn, to ¥43.5bn, principally consistent with the period's investment outflows, shareholder returns, and net financing outflow. PPE rose ¥26.0bn, or 28.3% YoY, to ¥117.6bn, increasing the fixed-asset base and execution dependence on asset utilization. Total equity increased 2.4% YoY to ¥416.3bn, while total assets increased 6.5% to ¥860.5bn; this modest dilution of the equity ratio to 47.4% from 49.4% is not currently a solvency concern. Goodwill is only 6.9% of equity and 0.63x EBITDA, so the balance sheet is not heavily dependent on M&A value retention. Lease obligations of ¥11.0bn and net defined-benefit liabilities of ¥12.8bn are additional long-term obligations to monitor alongside interest-bearing funding.

Notable B/S Changes

Short-term loans: -¥19.8bn (-46.8%) to ¥22.5bn - reduced short-term borrowing reliance and improved immediate liquidity risk. Cash and deposits: -¥22.8bn (-34.4%) to ¥43.5bn - cash was deployed amid investment outflows, shareholder returns, and net financing outflows; liquidity remains adequate but the cash buffer narrowed. PPE: +¥26.0bn (+28.3%) to ¥117.6bn - expansionary capital deployment increases the need for higher asset utilization and operating returns. Accounts receivable: +¥22.4bn (+7.2%) to ¥333.6bn - now 38.8% of assets and consistent with elevated 126-day DSO, making collections a key cash-flow monitor. Investment securities: +¥14.3bn (+19.8%) to ¥86.3bn - a sizable 10.0% of total assets, with valuation movements contributing to comprehensive-income volatility. Commercial paper: +¥34.5bn to ¥54.0bn - greater use of short-term market funding increases the importance of liquidity management despite strong current ratios.

Cash Flow Quality

Cash-flow quality is mixed but not weak in accounting terms. Operating cash flow was ¥29.3bn, exceeding ¥25.0bn of attributable net income and yielding an OCF/net-income ratio of 1.17x. The -0.5% accruals ratio likewise indicates limited accrual-driven inflation of reported profit. However, cash conversion from EBITDA was only 0.65x, below the 0.7x quality-alert threshold. The principal reason is the capital tied up in trading working capital: accounts receivable increased ¥22.4bn YoY to ¥333.6bn and represented 38.8% of total assets. DSO of 126 days is high, exceeding the 60-day alert threshold, and exposes cash flow to collection timing and counterparty-credit discipline. Inventories increased ¥4.5bn YoY to ¥151.4bn, with inventory days of 71 also above the 60-day threshold. The 128-day cash conversion cycle exceeds the 120-day warning threshold, indicating that operating growth and trading activity consume cash for an extended period before conversion into collections. Trade payables increased ¥14.6bn YoY to ¥165.8bn and contributed funding support, but that support does not eliminate the need to reduce receivable and inventory intensity. CapEx of ¥21.8bn exceeded depreciation and amortization of ¥12.1bn by 1.80x, signaling growth investment rather than maintenance-only spending. Operating cash flow less CapEx was positive at approximately ¥7.5bn, but reported free cash flow after all investing activities was negative ¥13.9bn because investing cash flow included ¥19.1bn of subsidiary acquisitions. Accordingly, internally generated cash did not fully fund the combined acquisition program, expanded capital expenditure, dividends, and buybacks during the period. The cash-flow outlook depends particularly on improving collection velocity and inventory turns while extracting operating cash returns from the enlarged asset base.

Dividend Sustainability

The disclosed interim dividend was ¥45 per share, and the calculated dividend-only payout ratio was 19.8%, which is conservative relative to earnings. Full-year guidance indicates a ¥100 per-share dividend, equivalent to an indicative payout ratio of approximately 33% against forecast EPS of ¥300.53. This prospective dividend level appears supported by forecast earnings and the company's healthy liquidity position. Cash dividends paid during the nine months were ¥9.6bn, well below operating cash flow of ¥29.3bn. However, reported free cash flow was negative ¥13.9bn after broader investing cash outflows, and CapEx-adjusted operating cash flow of approximately ¥7.5bn did not fully cover cash dividends paid. Share repurchases were substantial at ¥18.4bn, bringing dividends plus buybacks to ¥28.0bn. The resulting nine-month total return ratio was approximately 112% of attributable net income and approximately 96% of operating cash flow. Therefore, dividends alone appear sustainable, but the combination of dividends, elevated buybacks, acquisition spending, and expansionary CapEx is not fully covered by current-period internally generated cash. Future capital-return flexibility will depend on normalizing investment cash outflows and improving working-capital conversion.

Risk Assessment

Business risks include Working-capital risk is elevated: DSO of 126 days, inventory days of 71, and a 128-day cash conversion cycle can delay cash realization and heighten sensitivity to customer collection behavior and inventory valuation., Low operating efficiency remains a material risk: the 4.6% EBIT margin is below the 5% alert threshold, leaving earnings sensitive to procurement costs, product mix, pricing discipline, and SG&A inflation., Gross margin of 19.2% improved by about 91bp YoY but remains below the 20% quality-alert threshold; reversal of this improvement would have an outsized effect on profits given subdued revenue growth., The ¥19.1bn acquisition program and eight newly consolidated subsidiaries create integration, synergy-capture, and return-on-invested-capital risk., As a chemicals and materials trading and manufacturing group, the company remains exposed to customer demand cycles, feedstock and chemical-price volatility, foreign-exchange movements, and credit risk across a large trade-receivables book..

Financial risks include Cash conversion of 0.65x of EBITDA is below the 0.7x alert threshold despite OCF exceeding net income, indicating that earnings-to-cash conversion needs improvement., Cash and deposits fell ¥22.8bn YoY while investing cash flow was negative ¥43.2bn and share repurchases totaled ¥18.4bn, reducing the cash buffer during an investment-heavy period., Reported free cash flow was negative ¥13.9bn, and combined dividends and buybacks exceeded attributable net income for the nine-month period., Funding capacity is presently strong, with debt/EBITDA of 1.61x, EBITDA interest coverage of 18.20x, and a 183.4% current ratio, but commercial paper and other short-term funding require continued market access..

Key concerns include Highest priority: reduce the duration of receivables and inventory conversion so that profit growth translates more consistently into operating cash flow., High priority: preserve the gross-margin improvement and prevent SG&A, which increased 5.5% YoY, from continuing to grow materially faster than revenue., Medium priority: ensure that elevated CapEx and recent acquisitions produce returns commensurate with the higher fixed-asset and intangible-asset base., Medium priority: calibrate buybacks to free-cash-flow generation while investment spending remains elevated., Earnings comparison should account for the net extraordinary gain of ¥1.7bn, which supported pre-tax income but is not a recurring operating source..

Investment Implications

Key takeaways include Operating performance improved: operating income rose 7.1% and attributable profit rose 15.0% despite revenue growth of only 0.8%., Margin expansion was the principal earnings driver, with gross margin up about 91bp and operating margin up about 27bp YoY., Forecast execution is favorable through Q3, with operating-income progress of 81.6% versus a standard 75% benchmark., Balance-sheet leverage and interest-servicing capacity are conservative to moderate, with debt/EBITDA of 1.61x and EBITDA interest coverage of 18.20x., Cash generation requires attention because reported free cash flow was negative and working-capital days are elevated., Goodwill exposure is modest at 6.9% of equity and 0.63x EBITDA, limiting near-term goodwill-impairment sensitivity despite acquisition activity..

Metrics to watch include DSO, inventory days, and the cash conversion cycle, currently 126 days, 71 days, and 128 days, respectively., Gross margin and EBIT margin, currently 19.2% and 4.6%, particularly relative to SG&A growth., Operating cash flow/EBITDA conversion, currently 0.65x., Q4 operating-income delivery versus the ¥40.7bn full-year forecast., Returns and cash contribution from ¥19.1bn of subsidiary acquisitions and the 28.3% YoY increase in PPE., The relationship between share repurchases, dividends, and free-cash-flow generation..

Regarding relative positioning, The company presents as financially resilient, with strong liquidity, low debt/EBITDA, robust interest coverage, and limited goodwill concentration. Its annualized 8.0% ROE sits at the boundary between the stated concern and acceptable ranges, supported more by reasonable asset turnover and leverage than by a high-margin business model. Relative performance is therefore most dependent on sustaining recent gross-margin gains and improving cash discipline in its receivables- and inventory-intensive operating model.